1. Ocular Blood Flow Analysis Detects Microvascular Abnormalities in Impaired Glucose Tolerance
- Author
-
Auleen Millar, Aaron McCann, Paul Hamilton, Gary E. McVeigh, Catherine Quinn, Mark Harbinson, Christina E. Agnew, and Christopher J. Lockhart
- Subjects
medicine.medical_specialty ,Physiology ,business.industry ,Retinal ,Blood flow ,medicine.disease ,Placebo ,Microcirculation ,Impaired glucose tolerance ,chemistry.chemical_compound ,Insulin resistance ,medicine.anatomical_structure ,Endocrinology ,chemistry ,Physiology (medical) ,Internal medicine ,medicine ,Cardiology ,Vascular resistance ,Cardiology and Cardiovascular Medicine ,business ,Molecular Biology ,Pioglitazone ,medicine.drug - Abstract
Please cite this paper as: Quinn, Hamilton, McCann, Agnew, Millar, Lockhart, Harbinson and McVeigh (2011). Ocular Blood Flow Analysis Detects Microvascular Abnormalities in Impaired Glucose Tolerance. Microcirculation 18(7), 532–540. Abstract Objective: Waveform analysis has been used to assess vascular resistance and predict cardiovascular events. We aimed to identify microvascular abnormalities in patients with IGT using ocular waveform analysis. The effects of pioglitazone were also assessed. Methods: Forty patients with IGT and 24 controls were studied. Doppler velocity recordings were obtained from the central retinal, ophthalmic, and common carotid arteries, and sampled at 200 Hz. A discrete wavelet-based analysis method was employed to quantify waveforms. The RI was also determined. Patients with IGT were randomized to pioglitazone or placebo, and measurements were repeated after 12-week treatment. Results: In the ocular waveforms, significant differences in power spectra were observed in frequency band 4 (corresponding to frequencies between 6.25 and 12.50 Hz) between groups (p
- Published
- 2011
- Full Text
- View/download PDF